ABSL AMC Q2FY27: consol PAT falls 8% YoY to ₹221 Cr as ESOP costs squeeze margins

Aditya Birla Sun Life AMC's consolidated PAT fell 8.4% YoY to ₹220.98 Cr (Q2 FY26: ₹241.32 Cr) even as revenue from operations grew 4.9% YoY to ₹483.81 Cr, taking total income to ₹526.19 Cr. Net profit margin compressed to 42.0% from 47.7% a year ago. Sequentially PAT is down 28.6% from ₹309.49 Cr in Q1 FY27, though that decline is largely optical. Standalone PAT of ₹224.21 Cr (EPS ₹7.75) closely tracks the consolidated ₹220.98 Cr (EPS ₹7.64), so both bases tell the same story this quarter. Total expenses rose 20.5% YoY to ₹230.00 Cr, almost entirely on employee benefit expense, which jumped 32.8% YoY to ₹126.26 Cr as the company's July 2026 ESOP/PRSU grants (8,53,740 options at ₹1,017.50 and 1,93,728 PRSUs at ₹5, per the filing's Note 6) layered onto an already-elevated base; cash-flow disclosures show share-based payment charges of ₹13.08 Cr for H1 FY27 versus just ₹1.57 Cr in H1 FY26. Sequentially, the ₹9.92 Cr QoQ rise in employee cost (₹116.34 Cr to ₹126.26 Cr) matches management's own Q1 FY27 call commentary that ESOP costs had stabilized at a roughly ₹10 Cr/quarter incremental impact — the cost build is tracking as flagged, not a fresh surprise. The larger swing behind the QoQ PAT decline is other income: Q1 FY27 carried an elevated ₹162.20 Cr (on a stated treasury rebound), which normalized to ₹42.38 Cr this quarter — almost identical to the ₹45.15 Cr booked in Q2 FY26. Strip that out and the steadier signal is topline growth against rising people costs, not the headline QoQ drop. No brokerage preview or consensus PAT estimate specific to this quarter could be sourced, so the street comparison is marked unknown rather than inferred. Against the AMC's own prior guidance — yields maintained at 63-64 bps (equity) and 24-25 bps (debt) post-TER, passive AUM growing with telescoping pricing, alternate revenue near 4% of total, and employee costs stabilizing post-ESOP rollout — the quarter is broadly on-track: the ~₹10 Cr/quarter ESOP cost addition matches guidance precisely, and 4.9% YoY revenue growth shows no sign of material yield compression. No management press release accompanied this filing beyond the regulatory board-outcome letter, so there is no company framing to reconcile against the numbers. Of the quarter's other corporate developments, the CISO change (Basil Dange's exit, September 18) and the cancelled investor-conference participation (August 11) are governance/IR items with no P&L impact visible this quarter. H1 FY27 consolidated PAT of ₹530.47 Cr is up a modest 2.3% over H1 FY26's ₹518.43 Cr, underscoring that the full-year trend is flatter than the quarter's YoY revenue growth alone suggests, with employee-cost inflation the key factor to watch as the new ESOP/PRSU tranche vests over coming quarters.